Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1990 Nov 1;271(3):773–777. doi: 10.1042/bj2710773

Glycosaminoglycans inhibit formation of the 140 kDa insulin-like growth factor-binding protein complex.

R C Baxter 1
PMCID: PMC1149630  PMID: 1700901

Abstract

The 140 kDa insulin-like growth factor (IGF)-binding protein complex in human serum consists of three subunits: an acid-labile, non-IGF-binding glycoprotein (alpha-subunit), an IGF-binding glycoprotein known as BP-53 or IGFBP-3 (beta-subunit), and IGF-I or IGF-II (gamma-subunit). This study investigates the regulation, by salt and glycosaminoglycans, of ternary (alpha-beta-gamma) complex formation, measured by incubating radioiodinated alpha-subunit with a mixture of IGF-I and IGFBP-3 and precipitating bound radioactivity with an anti-IGFBP-3 antiserum. Increasing NaCl concentrations progressively decreased ternary complex formation without any effect on binary (beta-gamma) complex formation. In 0.15 M-NaCl, the association constant for the ternary complex was 0.318 +/- 0.092 nM-1, 100-fold lower than that for the binary complex. Glycosaminoglycans also inhibited ternary complex formation without affecting the binary complex. Heparin [50% inhibition at 0.27 +/- 0.08 units/ml (1.5 +/- 0.4 micrograms/ml)] was more potent than heparan sulphate (50% inhibition at 15 +/- 7 micrograms/ml), with chondroitin sulphate even less potent. The inhibition by heparin was due principally to a decrease in binding affinity, from 0.604 +/- 0.125 to 0.151 +/- 0.024 nM-1 in the presence of 0.25 units of heparin/ml, with a slight decrease in the number of apparent binding sites from 1.05 +/- 0.08 to 0.85 +/- 0.15 mol of alpha-subunit bound/mol of beta-subunit. Since the ternary IGF-binding protein complex cannot cross the capillary barrier, it is proposed that a decrease in the affinity of the complex, mediated by circulating or cell-associated glycosaminoglycans, may be important in the passage of IGFs and IGFBP-3 to the tissues.

Full text

PDF
773

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bar R. S., Boes M., Yorek M. Processing of insulin-like growth factors I and II by capillary and large vessel endothelial cells. Endocrinology. 1986 Mar;118(3):1072–1080. doi: 10.1210/endo-118-3-1072. [DOI] [PubMed] [Google Scholar]
  2. Baxter R. C., Brown A. S. Purification of tracer for somatomedin C radioimmunoassay by hydrophobic interaction chromatography. Clin Chem. 1982 Mar;28(3):485–487. [PubMed] [Google Scholar]
  3. Baxter R. C. Characterization of the acid-labile subunit of the growth hormone-dependent insulin-like growth factor binding protein complex. J Clin Endocrinol Metab. 1988 Aug;67(2):265–272. doi: 10.1210/jcem-67-2-265. [DOI] [PubMed] [Google Scholar]
  4. Baxter R. C. Circulating levels and molecular distribution of the acid-labile (alpha) subunit of the high molecular weight insulin-like growth factor-binding protein complex. J Clin Endocrinol Metab. 1990 May;70(5):1347–1353. doi: 10.1210/jcem-70-5-1347. [DOI] [PubMed] [Google Scholar]
  5. Baxter R. C., Martin J. L., Beniac V. A. High molecular weight insulin-like growth factor binding protein complex. Purification and properties of the acid-labile subunit from human serum. J Biol Chem. 1989 Jul 15;264(20):11843–11848. [PubMed] [Google Scholar]
  6. Baxter R. C., Martin J. L. Binding proteins for insulin-like growth factors in adult rat serum. Comparison with other human and rat binding proteins. Biochem Biophys Res Commun. 1987 Aug 31;147(1):408–415. doi: 10.1016/s0006-291x(87)80136-5. [DOI] [PubMed] [Google Scholar]
  7. Baxter R. C., Martin J. L. Binding proteins for the insulin-like growth factors: structure, regulation and function. Prog Growth Factor Res. 1989;1(1):49–68. doi: 10.1016/0955-2235(89)90041-0. [DOI] [PubMed] [Google Scholar]
  8. Baxter R. C., Martin J. L. Radioimmunoassay of growth hormone-dependent insulinlike growth factor binding protein in human plasma. J Clin Invest. 1986 Dec;78(6):1504–1512. doi: 10.1172/JCI112742. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Baxter R. C., Martin J. L. Structure of the Mr 140,000 growth hormone-dependent insulin-like growth factor binding protein complex: determination by reconstitution and affinity-labeling. Proc Natl Acad Sci U S A. 1989 Sep;86(18):6898–6902. doi: 10.1073/pnas.86.18.6898. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Baxter R. C. The insulin-like growth factors and their binding proteins. Comp Biochem Physiol B. 1988;91(2):229–235. doi: 10.1016/0305-0491(88)90137-x. [DOI] [PubMed] [Google Scholar]
  11. Baxter R. C., de Mellow J. S. Measurement of insulin-like growth factor-II by radioreceptor assay using ovine placental membranes. Clin Endocrinol (Oxf) 1986 Mar;24(3):267–278. doi: 10.1111/j.1365-2265.1986.tb03267.x. [DOI] [PubMed] [Google Scholar]
  12. Binoux M., Hossenlopp P. Insulin-like growth factor (IGF) and IGF-binding proteins: comparison of human serum and lymph. J Clin Endocrinol Metab. 1988 Sep;67(3):509–514. doi: 10.1210/jcem-67-3-509. [DOI] [PubMed] [Google Scholar]
  13. Blum W. F., Jenne E. W., Reppin F., Kietzmann K., Ranke M. B., Bierich J. R. Insulin-like growth factor I (IGF-I)-binding protein complex is a better mitogen than free IGF-I. Endocrinology. 1989 Aug;125(2):766–772. doi: 10.1210/endo-125-2-766. [DOI] [PubMed] [Google Scholar]
  14. Clemmons D. R., Underwood L. E., Chatelain P. G., Van Wyk J. J. Liberation of immunoreactive somatomedin-C from its binding proteins by proteolytic enzymes and heparin. J Clin Endocrinol Metab. 1983 Feb;56(2):384–389. doi: 10.1210/jcem-56-2-384. [DOI] [PubMed] [Google Scholar]
  15. Cornell H. J., Enberg G., Herington A. C. Preferential association of the insulin-like growth factors I and II with metabolically inactive and active carrier-bound complexes in serum. Biochem J. 1987 Feb 1;241(3):745–750. doi: 10.1042/bj2410745. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Daughaday W. H., Ward A. P., Goldberg A. C., Trivedi B., Kapadia M. Characterization of somatomedin binding in human serum by ultracentrifugation and gel filtration. J Clin Endocrinol Metab. 1982 Nov;55(5):916–921. doi: 10.1210/jcem-55-5-916. [DOI] [PubMed] [Google Scholar]
  17. De Mellow J. S., Baxter R. C. Growth hormone-dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-I-stimulated DNA synthesis in human skin fibroblasts. Biochem Biophys Res Commun. 1988 Oct 14;156(1):199–204. doi: 10.1016/s0006-291x(88)80824-6. [DOI] [PubMed] [Google Scholar]
  18. Furlanetto R. W. The somatomedin C binding protein: evidence for a heterologous subunit structure. J Clin Endocrinol Metab. 1980 Jul;51(1):12–19. doi: 10.1210/jcem-51-1-12. [DOI] [PubMed] [Google Scholar]
  19. Hall K., Brandt J., Enberg G., Fryklund L. Immunoreactive somatomedin A in human serum. J Clin Endocrinol Metab. 1979 Feb;48(2):271–278. doi: 10.1210/jcem-48-2-271. [DOI] [PubMed] [Google Scholar]
  20. Hardouin S., Hossenlopp P., Segovia B., Seurin D., Portolan G., Lassarre C., Binoux M. Heterogeneity of insulin-like growth factor binding proteins and relationships between structure and affinity. 1. Circulating forms in man. Eur J Biochem. 1987 Dec 30;170(1-2):121–132. doi: 10.1111/j.1432-1033.1987.tb13676.x. [DOI] [PubMed] [Google Scholar]
  21. Hintz R. L., Liu F., Rosenfeld R. G., Kemp S. F. Plasma somatomedin-binding proteins in hypopituitarism: changes during growth hormone therapy. J Clin Endocrinol Metab. 1981 Jul;53(1):100–104. doi: 10.1210/jcem-53-1-100. [DOI] [PubMed] [Google Scholar]
  22. Hök M., Kjellén L., Johansson S. Cell-surface glycosaminoglycans. Annu Rev Biochem. 1984;53:847–869. doi: 10.1146/annurev.bi.53.070184.004215. [DOI] [PubMed] [Google Scholar]
  23. Kjellén L., Oldberg A., Hök M. Cell-surface heparan sulfate. Mechanisms of proteoglycan-cell association. J Biol Chem. 1980 Nov 10;255(21):10407–10413. [PubMed] [Google Scholar]
  24. Martin J. L., Baxter R. C. Insulin-like growth factor-binding protein from human plasma. Purification and characterization. J Biol Chem. 1986 Jul 5;261(19):8754–8760. [PubMed] [Google Scholar]
  25. Norling B., Glimelius B., Wasteson A. Heparan sulfate proteoglycan of cultured cells: demonstration of a lipid- and a matrix-associated form. Biochem Biophys Res Commun. 1981 Dec 31;103(4):1265–1272. doi: 10.1016/0006-291x(81)90259-x. [DOI] [PubMed] [Google Scholar]
  26. Scott C. D., Martin J. L., Baxter R. C. Production of insulin-like growth factor I and its binding protein by adult rat hepatocytes in primary culture. Endocrinology. 1985 Mar;116(3):1094–1101. doi: 10.1210/endo-116-3-1094. [DOI] [PubMed] [Google Scholar]
  27. Ui M., Shimonaka M., Shimasaki S., Ling N. An insulin-like growth factor-binding protein in ovarian follicular fluid blocks follicle-stimulating hormone-stimulated steroid production by ovarian granulosa cells. Endocrinology. 1989 Aug;125(2):912–916. doi: 10.1210/endo-125-2-912. [DOI] [PubMed] [Google Scholar]
  28. Walton P. E., Baxter R. C., Burleigh B. D., Etherton T. D. Purification of the serum acid-stable insulin-like growth factor binding protein from the pig (Sus scrofa). Comp Biochem Physiol B. 1989;92(3):561–567. doi: 10.1016/0305-0491(89)90132-6. [DOI] [PubMed] [Google Scholar]
  29. Wilkins J. R., D'Ercole A. J. Affinity-labeled plasma somatomedin-C/insulinlike growth factor I binding proteins. Evidence of growth hormone dependence and subunit structure. J Clin Invest. 1985 Apr;75(4):1350–1358. doi: 10.1172/JCI111836. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Zapf J., Born W., Chang J. Y., James P., Froesch E. R., Fischer J. A. Isolation and NH2-terminal amino acid sequences of rat serum carrier proteins for insulin-like growth factors. Biochem Biophys Res Commun. 1988 Nov 15;156(3):1187–1194. doi: 10.1016/s0006-291x(88)80758-7. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES